Cardiology - Case Reports
April 6, 2021
Vol. 91 No. 3 (2021)
https://doi.org/10.4081/monaldi.2021.1668

Apparently normal epicardial coronaries in a patient with inferior wall myocardial infarction on the background of mild coronavirus disease-2019: take a second look!

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
COVID-19, ST elevation myocardial infarction, coronary angiography, thrombosis
2779
Views
799
Downloads

Authors

Barun Kumar
Department of Cardiology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India.
Ashwin Kodliwadmath
ashrocks33@gmail.com
Department of Cardiology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India.
Amar Upadhyay
Department of Pediatrics, Doon Medical College, Dehradun, India.
Anupam Singh
Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India.
Nanda N
Department of Endocrinology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India.

The coronary angiographic (CAG) findings of ST elevation myocardial infarction (STEMI) in patients of coronavirus disease 2019 (COVID-19) range from increased coronary artery thrombus burden to normal coronaries due to STEMI mimics. Here we report the case of a 45-year-old gentleman who presented with evolved inferior wall myocardial infarction with ongoing angina along with mild COVID-19. CAG showed normal epicardial coronaries except for distal right posterior descending coronary artery (RPDA) 100% occlusion on careful examination. He was treated for the myocardial infarction with medical management along with treatment of COVID-19. The importance of our case is to highlight the possibility of distal total occlusion of small coronary branches which may be missed if not carefully looked for as a normal CAG in COVID-19 patient will require only supportive therapy, while the finding of distal 100% occlusion of RPDA deemed us to prescribe optimal medical therapy as per acute myocardial infarction protocol along with treatment for COVID-19.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J Am Heart Assoc 2021;10:e019650. DOI: https://doi.org/10.1161/JAHA.120.019650
Roffi M, Guagliumi G, Ibanez B. The obstacle course of reperfusion for ST-segment–elevation myocardial infarction in the COVID-19 pandemic. Circulation 2020;141:1951–3. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047523
Bennett CE, Anavekar NS, Gulati R, et al. ST-segment elevation, myocardial injury, and suspected or confirmed COVID-19 patients: diagnostic and treatment uncertainties. Mayo Clin Proc 2020;95:1107-11. DOI: https://doi.org/10.1016/j.mayocp.2020.04.005
Cizgici AY, Agus HZ, Yildiz M. COVID-19 myopericarditis: it should be kept in mind in today's conditions. Am J Emerg Med 2020;38:1547. DOI: https://doi.org/10.1016/j.ajem.2020.04.080
Rapkiewicz AV, Mai X, Carsons SE, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine 2020;24:100434. DOI: https://doi.org/10.1016/j.eclinm.2020.100434
Becker RC. COVID-19 update: COVID-19-associated coagulopathy. J Thromb Thrombols 2020;50:54–67. DOI: https://doi.org/10.1007/s11239-020-02134-3
Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020;324:799–801. DOI: https://doi.org/10.1001/jama.2020.13372
Vidivich MI, Fischman DL, Bates ER. COVID-19 STEMI 2020 it’s not what you know, it’s how you think. JACC Case Rep 2020 27;2:1289-90. DOI: https://doi.org/10.1016/j.jaccas.2020.04.016
Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020;22:911–5. DOI: https://doi.org/10.1002/ejhf.1828
Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666–87. DOI: https://doi.org/10.1093/cvr/cvaa106
Avila J, Long B, Holladay D, Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med 2021;39:213-8. DOI: https://doi.org/10.1016/j.ajem.2020.09.065
Welt FGP, Shah PB, Aronow HD, et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC’s interventional council and SCAI. J Am Coll Cardiol 2020;75:2372–5. DOI: https://doi.org/10.1016/j.jacc.2020.03.021
Mahmud E, Dauerman HL, Welt FGP, et al. Management of acute myocardial infarction during the COVID-19 pandemic: a position statement from the society for cardiovascular angiography and interventions (SCAI), the American college of cardiology (ACC), and the American college of emergency physicians (ACEP). J Am Coll Cardiol 2020;76:1375-84. DOI: https://doi.org/10.1016/j.jacc.2020.04.039

How to Cite



“Apparently Normal Epicardial Coronaries in a Patient With Inferior Wall Myocardial Infarction on the Background of Mild Coronavirus Disease-2019: Take a Second Look!”. 2021. Monaldi Archives for Chest Disease 91 (3). https://doi.org/10.4081/monaldi.2021.1668.
Copyright (c) 2021 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.